title: Long-term follow-up of corneal graft survival following bone marrow transplantation in the Maroteaux-Lamy syndrome.
abstract: OBJECTIVE
  To present a case of Maroteaux-Lamy syndrome (MLS, mucopolysaccharidosis [MPS] type VI) who underwent bone marrow transplantation (BMT) for gene transfer at the age of 13, and penetrating keratoplasty at the age of 17, and maintained clear corneal grafts bilaterally for 13 years. To our knowledge, this is the longest follow-up reported on corneal graft survival in a patient with MLS and BMT.
  
  
  METHODS
  In 1982, BMT was successfully performed on a 13-year-old girl with MLS with growth retardation, typical facial features, skeletal and joint deformities, hepatosplenomegaly, cardiopulmonary dysfunction, and corneal clouding. Corneal transplantation was done on the left eye in 1986, and on the right eye in 1987 (6 months later) without difficulty or complication.
  
  
  RESULTS
  Thirteen years postoperatively, the patient was systemically well, and both eyes retained clear corneal grafts.
  
  
  CONCLUSIONS
  BMT retarded further dysfunction from MLS, and the corneal transplants retained clarity. Further controlled studies with longer follow-up are required to establish the efficacy of BMT in ocular manifestations of MPS or MLS.
authors.affiliation: Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
authors.forename: O O
authors.initials: OO
authors.lastname: Uçakhan
authors.forename: S E
authors.initials: SE
authors.lastname: Brodie
authors.forename: R
authors.initials: R
authors.lastname: Desnick
authors.forename: J
authors.initials: J
authors.lastname: Willner
authors.forename: P A
authors.initials: PA
authors.lastname: Asbell
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D003315:Cornea / Q000502:physiology*; D003318:Corneal Opacity / Q000503:physiopathology / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D015948:Keratoplasty, Penetrating / Q000502:physiology*; D009087:Mucopolysaccharidosis VI / Q000628:therapy*; D014792:Visual Acuity